Literature DB >> 9733662

Olanzapine 10-N-glucuronide. A tertiary N-glucuronide unique to humans.

K Kassahun1, E Mattiuz, R Franklin, T Gillespie.   

Abstract

In humans, a major metabolite of the atypical antipsychotic olanzapine in the plasma and in the urine was found to be an N-glucuronide. Unexpectedly, the glucuronic acid moiety was linked through a nitrogen of the benzodiazepine nucleus of olanzapine by way of a secondary amine linkage, rather than through a nitrogen on the piperazine substituent of the nucleus, to give a quaternary ammonium glucuronide. Derivatization with phenylisothiocyanate to yield a thiourea adduct indicated that conjugation occurred via a secondary amine. Subsequently, mass spectrometry and nuclear magnetic resonance studies with the isolated metabolite and later with the synthesized metabolite indicated that the glucuronide was linked at the 10- position of olanzapine. This phase 2 metabolite was only detected in the plasma and urine of human subjects and not in mice, rats, or monkeys; a trace of this metabolite was detected in dog urine. The N-10 glucuronide was resistant to enzymatic and base hydrolysis but was cleaved under acidic conditions. Formation of an N-glucuronide metabolite directly with the benzodiazepine nucleus has not previously been reported.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9733662

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  5 in total

1.  Olanzapine metabolism and the significance of UGT1A448V and UGT2B1067Y variants.

Authors:  Kathryn Kelly Erickson-Ridout; Junjia Zhu; Philip Lazarus
Journal:  Pharmacogenet Genomics       Date:  2011-09       Impact factor: 2.089

2.  Contribution of N-glucuronidation to efavirenz elimination in vivo in the basal and rifampin-induced metabolism of efavirenz.

Authors:  Doo-Yeoun Cho; Evan T Ogburn; David Jones; Zeruesenay Desta
Journal:  Antimicrob Agents Chemother       Date:  2011-01-31       Impact factor: 5.191

3.  Characterization of nuciferine metabolism by P450 enzymes and uridine diphosphate glucuronosyltransferases in liver microsomes from humans and animals.

Authors:  Yan-liu LU; Yu-qi HE; Miao WANG; Li ZHANG; Li YANG; Zheng-tao WANG; Guang JI
Journal:  Acta Pharmacol Sin       Date:  2010-12       Impact factor: 6.150

4.  In vitro and in vivo oxidative metabolism and glucuronidation of anastrozole.

Authors:  Landry K Kamdem; Yong Liu; Vered Stearns; Susan A Kadlubar; Jacqueline Ramirez; Stacie Jeter; Karineh Shahverdi; Bryan A Ward; Evan Ogburn; Mark J Ratain; David A Flockhart; Zeruesenay Desta
Journal:  Br J Clin Pharmacol       Date:  2010-12       Impact factor: 4.335

Review 5.  Biotransformation of post-clozapine antipsychotics: pharmacological implications.

Authors:  S Caccia
Journal:  Clin Pharmacokinet       Date:  2000-05       Impact factor: 6.447

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.